Résultats de la recherche
10
Tout
Rechercher les filtres
Mot-clé
financial results
Digi Power X to Announce 2024 Year End Financial Results on March 31st
26 mars 2025 07h30 HE
|
Digi Power X Inc.
MIAMI, March 26, 2025 (GLOBE NEWSWIRE) -- Digi Power X Inc. (“Digi Power X” or the “Company”) (Nasdaq: DGXX / TSXV: DGX), an innovative energy infrastructure company that develops cutting-edge data...
Odysight.ai Reports Full Year 2024 Financial Results and Provides Business Update
26 mars 2025 07h05 HE
|
Odysight.ai Inc.
OMER, Israel, March 26, 2025 (GLOBE NEWSWIRE) -- Odysight.ai Inc. (NASDAQ: ODYS), a leading provider of visual based predictive maintenance (PdM) and condition-based monitoring (CBM) solutions,...
Nortech Systems Incorporated to Report Fourth Quarter 2024 Financial Results and Hold a Conference Call on March 31, 2025
25 mars 2025 16h05 HE
|
Nortech Systems Incorporated
MINNEAPOLIS, March 25, 2025 (GLOBE NEWSWIRE) -- Nortech Systems Incorporated (Nasdaq: NSYS) (the “Company”), a leading provider of engineering and manufacturing solutions for complex electromedical...
Wrap Technologies, Inc. to Report Fourth Quarter 2024 and Full Year Financial Results on Monday, March 31, 2025 at 4:30 p.m. ET
24 mars 2025 16h33 HE
|
Wrap Technologies, Inc.
Wrap Technologies, Inc. to Report Fourth Quarter 2024 and Full Year Financial Results on Monday, March 31, 2025 at 4:30 p.m. ET
Foresight Announces Fourth Quarter and Full Year 2024 Financial Results
24 mars 2025 16h10 HE
|
Foresight Autonomous Holdings Ltd.
NESS ZIONA, Israel, March 24, 2025 (GLOBE NEWSWIRE) -- Foresight Autonomous Holdings Ltd., (Nasdaq and TASE: FRSX) (“Foresight” or the “Company”), an innovator in 3D perception systems, today...
NEXGEL Reports Record Fourth Quarter and Full Year 2024 Financial Results
24 mars 2025 16h05 HE
|
NEXGEL, INC.
Fourth quarter 2024 revenue totaled $3.04 million, an increase of 181%, as compared to $1.08 million for the same period the prior year Full year 2024 revenue totaled $8.69 million, an increase of...
Moleculin Reports Full Year 2024 Financial Results and Provides Corporate Update
24 mars 2025 07h05 HE
|
Moleculin Biotech, Inc.
– Continued progress in pivotal, adaptive Phase 3 clinical trial (the “MIRACLE” trial) toward first subject treated, on track to take place in the first quarter of 2025 – Multiple subjects currently...
Biofrontera Inc. Reports Record Fiscal Year 2024 Financial Results and Provides a Business Update
21 mars 2025 08h00 HE
|
Biofrontera Inc.
Conference scheduled for Friday, March 21, 2025 at 10:00 a.m. Eastern time Woburn, Mass., March 21, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical...
Caledonia Mining Corporation Plc: Short delay to the publication of financial results for the year ended December 31, 2024
21 mars 2025 03h00 HE
|
Caledonia Mining Corporation Plc
ST HELIER, Jersey, March 21, 2025 (GLOBE NEWSWIRE) -- Caledonia Mining Corporation Plc (“Caledonia” or “the Company”) (NYSE AMERICAN: CMCL; AIM: CMCL; VFEX: CMCL) announces that in the course of...
InflaRx Reports Full Year 2024 Results and Highlights Key Achievements and Expected Milestones
20 mars 2025 07h30 HE
|
InflaRx N.V.
Received European Commission approval for GOHIBIC® (vilobelimab) for the treatment of SARS-CoV-2-induced acute respiratory distress syndrome (ARDS)Achieved 30-patient recruitment milestone in Phase 3...